STOCK TITAN

Holder of COR plans Rule 144 sale of 4031 NYSE common shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of COR common stock has filed a Rule 144 notice to sell 4031 shares on the NYSE, with an aggregate market value of $1383580.29, out of 193993444 shares of this class outstanding.

The shares were acquired through restricted stock vesting from the issuer as compensation on four dates in 2025, in amounts of 1375, 1032, 1022, and 602 shares, with payment recorded on the same dates. The planned sale date is approximately December 17, 2025, through Fidelity Brokerage Services LLC. The person signing the notice represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the COR Rule 144 filing disclose?

It discloses that a holder of COR common stock plans to sell 4031 shares on the NYSE under Rule 144.

How many COR shares are planned to be sold and what is their market value?

The notice covers the planned sale of 4031 common shares with an aggregate market value of $1383580.29.

When were the COR shares being sold acquired and how?

The shares were acquired via restricted stock vesting from the issuer as compensation on 09/30/2025, 11/08/2025, 11/09/2025, and 11/20/2025, in blocks of 1375, 1032, 1022, and 602 shares.

When and where are the COR shares expected to be sold?

The approximate sale date is 12/17/2025, and the shares are to be sold on the NYSE through Fidelity Brokerage Services LLC.

How many COR common shares are outstanding according to this notice?

The notice states that there are 193993444 COR common shares outstanding.

What representation does the selling holder make about COR’s information disclosure?

By signing, the person represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and acknowledges the federal criminal consequences of intentional misstatements or omissions.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

66.07B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN